In NSTE-ACS patients , the primary endpoint was reduced with ticagrelor vs. clopidogrel -LSB- @ vs. @ % ; hazard ratio ( HR ) @ ; @ % confidence interval ( CI ) = @-@ @ -RSB- , as was myocardial infarction ( @ vs. @ % ; HR @ ; @ % CI = @-@ @ ) , cardiovascular death ( @ vs. @ % ; HR @ ; @ % CI = @-@ @ ) , and all-cause death ( @ vs. @ % ; HR @ ; @ % CI = @-@ @ ) .